AZN vs SAIL · P/E 28, $288.38B cap vs rev $1.07B
AstraZeneca PLC (AZN) versus SailPoint, Inc. Common Stock (SAIL) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
SailPoint, Inc. Common Stock (SAIL) is a software - infrastructure company listed on NASDAQ.
AZN does not have a complete income-statement cache yet.
Latest reported SAIL revenue for 2026-01-31 was $1.07B. Net income was -$270.1M. Revenue was up 24.4% from 2025-01-31 to 2026-01-31. SAIL currently screens at market cap $8.06B.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. SAIL currently screens at market cap $8.06B.
Not investment advice. Open the AZN and SAIL stock pages for the full models.
Not investment advice.